Remdesivir to remain scarce till April 20, officials point at production cycle, overprescription
Prajakta Joshi
The shortage of Remdesivir in Pune is going to last till at least April 20, Dinesh Khivasara, Assistant Commissioner of Food and Drugs Administration (FDA) said. Pune and several other COVID hotspots in Maharashtra are facing an acute shortage of the antiviral drug administered via injections, which is widely being used to treat the hospitalised COVID patients.